These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22512592)

  • 1. Perspectives on the development of antioxidant antiepileptogenic agents.
    Rowles J; Olsen M
    Mini Rev Med Chem; 2012 Sep; 12(10):1015-27. PubMed ID: 22512592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting oxidative stress component in the therapeutics of epilepsy.
    Azam F; Prasad MV; Thangavel N
    Curr Top Med Chem; 2012; 12(9):994-1007. PubMed ID: 22352862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress in epilepsy.
    Geronzi U; Lotti F; Grosso S
    Expert Rev Neurother; 2018 May; 18(5):427-434. PubMed ID: 29651881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selected Molecular Targets for Antiepileptogenesis.
    Pawlik MJ; Miziak B; Walczak A; Konarzewska A; Chrościńska-Krawczyk M; Albrecht J; Czuczwar SJ
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Dysfunction and Oxidative Stress in Epilepsy.
    Pearson-Smith JN; Patel M
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29117123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation and reactive oxygen species as disease modifiers in epilepsy.
    Terrone G; Balosso S; Pauletti A; Ravizza T; Vezzani A
    Neuropharmacology; 2020 May; 167():107742. PubMed ID: 31421074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy.
    Löscher W
    Epilepsy Res; 2002 Jun; 50(1-2):105-23. PubMed ID: 12151122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seizures, antiepileptics, antioxidants and oxidative stress: an insight for researchers.
    Devi PU; Manocha A; Vohora D
    Expert Opin Pharmacother; 2008 Dec; 9(18):3169-77. PubMed ID: 19040338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferulic acid exhibits antiepileptogenic effect and prevents oxidative stress and cognitive impairment in the kindling model of epilepsy.
    Hassanzadeh P; Arbabi E; Atyabi F; Dinarvand R
    Life Sci; 2017 Jun; 179():9-14. PubMed ID: 27534908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candidate drug targets for prevention or modification of epilepsy.
    Varvel NH; Jiang J; Dingledine R
    Annu Rev Pharmacol Toxicol; 2015; 55():229-47. PubMed ID: 25196047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interweaving epilepsy and neurodegeneration: Vitamin E as a treatment approach.
    Upaganlawar AB; Wankhede NL; Kale MB; Umare MD; Sehgal A; Singh S; Bhatia S; Al-Harrasi A; Najda A; Nurzyńska-Wierdak R; Bungau S; Behl T
    Biomed Pharmacother; 2021 Nov; 143():112146. PubMed ID: 34507113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative injury in epilepsy: potential for antioxidant therapy?
    Costello DJ; Delanty N
    Expert Rev Neurother; 2004 May; 4(3):541-53. PubMed ID: 15853548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination antioxidant therapy prevents epileptogenesis and modifies chronic epilepsy.
    Shekh-Ahmad T; Lieb A; Kovac S; Gola L; Christian Wigley W; Abramov AY; Walker MC
    Redox Biol; 2019 Sep; 26():101278. PubMed ID: 31382215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of the phenosanic acid in the combined treatment of patients with epilepsy].
    Voronkova KV; Alieva AM; Nikitin IG; Musina GM; Surskaya EV; Zaitseva OS; Mashkevich NG; Gomonova LV; Petrukhin AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(2):151-157. PubMed ID: 36843473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers for epileptogenesis and its treatment.
    Engel J; Pitkänen A
    Neuropharmacology; 2020 May; 167():107735. PubMed ID: 31377200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting crosstalk between Nuclear factor (erythroid-derived 2)-like 2 and Nuclear factor kappa beta pathway by Nrf2 activator dimethyl fumarate in epileptogenesis.
    Singh N; Vijayanti S; Saha L
    Int J Neurosci; 2018 Oct; 128(10):987-994. PubMed ID: 29447051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-mediated neuroprotection and antiepileptogenesis: animal data.
    Pitkänen A
    Neurology; 2002 Nov; 59(9 Suppl 5):S27-33. PubMed ID: 12428029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combating oxidative stress in epilepsy: design, synthesis, quantum chemical studies and anticonvulsant evaluation of 1-(substituted benzylidene/ethylidene)-4-(naphthalen-1-yl)semicarbazides.
    Azam F; El-Gnidi BA; Alkskas IA
    Eur J Med Chem; 2010 Jul; 45(7):2817-26. PubMed ID: 20356656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to Find Candidate Drug-targets for Antiepileptogenic Therapy?
    Yu N; Lin XJ; Di Q
    Curr Neuropharmacol; 2020; 18(7):624-635. PubMed ID: 31989901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.